BMO
CELG

Beck Mack & Oliver’s Celgene Corp CELG Stock Holding History

Beck Mack & Oliver’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,837
Closed -$679K – 223
2019
Q3 		$679K Hold
6,837
– – 0.02% 129
2019
Q2 		$632K Sell
6,837
-340
-5% -$32.3K 0.02% 142
2019
Q1 		$677K Sell
7,177
-60
-0.8% -$5.25K 0.02% 138
2018
Q4 		$464K Hold
7,237
– – 0.02% 151
2018
Q3 		$648K Hold
7,237
– – 0.02% 149
2018
Q2 		$575K Hold
7,237
– – 0.02% 147
2018
Q1 		$646K Buy
7,237
+400
+6% +$38.4K 0.02% 139
2017
Q4 		$714K Buy
6,837
+355
+5% +$40.1K 0.02% 134
2017
Q3 		$945K Buy
6,482
+45
+0.7% +$6.13K 0.03% 125
2017
Q2 		$836K Hold
6,437
– – 0.03% 126
2017
Q1 		$801K Hold
6,437
– – 0.03% 125
2016
Q4 		$745K Hold
6,437
– – 0.03% 127
2016
Q3 		$673K Buy
6,437
+37
+0.6% +$4K 0.02% 145
2016
Q2 		$631K Buy
6,400
+200
+3% +$20.7K 0.02% 176
2016
Q1 		$621K Hold
6,200
– – 0.02% 176
2015
Q4 		$743K Sell
6,200
-7,350
-54% -$850K 0.03% 171
2015
Q3 		$1.47M Buy
13,550
+200
+1% +$24.8K 0.04% 135
2015
Q2 		$1.54M Hold
13,350
– – 0.04% 137
2015
Q1 		$1.54M Hold
13,350
– – 0.04% 142
2014
Q4 		$1.49M Sell
13,350
-200
-1% -$21.1K 0.04% 143
2014
Q3 		$1.28M Sell
13,550
-150
-1% -$13.5K 0.03% 159
2014
Q2 		$1.18M Hold
13,700
– – 0.03% 162
2014
Q1 		$956K Sell
13,700
-1,280
-9% -$101K 0.02% 179
2013
Q4 		$1.27M Sell
14,980
-720
-5% -$57K 0.03% 158
2013
Q3 		$1.21M Sell
15,700
-2,600
-14% -$182K 0.03% 160
2013
Q2 		$1.07M Buy
+18,300
New +$1.1M 0.03% 169

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Beck Mack & Oliver's CELG Position: Q4 2019 in Review

Beck Mack & Oliver sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,837 shares — an estimated $679K sold.

Beck Mack & Oliver first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.54M in Q2 2015. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Beck Mack & Oliver reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Beck Mack & Oliver sold 6,837 Celgene Corp shares in Q4 2019, an estimated $679K.
  • Beck Mack & Oliver first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Beck Mack & Oliver's Celgene Corp position peaked at $1.54M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Beck Mack & Oliver's 13F filing for Q4 2019, filed 7 Feb 2020.